What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2026-08-17 compared with 2026-05-19 · 19 added, 74 removed, 22 unchanged (81% of the section changed)

Other Information.

the quarter ended March 31, 2026, none of the Company’s directors or officers adopted , modified , or terminated a “Rule 10b5-1

the quarter ended June 30, 2026, none of the Company’s directors or officers adopted , modified , or terminated a “Rule 10b5-1

trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408(a) of Regulation

following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

Amended and Restated Membership Interest Purchase Agreement dated June 16, 2024, by and between Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) and Nikul Panchal (incorporated by reference to Exhibit 10.1 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Membership Interest Purchase Agreement dated May 11, 2023, by and among Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.), Wellgistics, LLC, Strategix Global LLC, Nomad Capital LLC, Jouska Holdings LLC, and Brian Norton, as amended (incorporated by reference to Exhibit 5.2 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on March 6, 2025).

Seventh Amendment to Membership Interest Purchase Agreement dated May 11, 2023, by and among Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.), Wellgistics, LLC, Strategix Global LLC, Nomad Capital LLC, Jouska Holdings LLC, and Brian Norton, as amended (incorporated by reference to Exhibit 2.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 18, 2025).

Agreement and Plan of Merger dated April 8, 2025, by and among Wellgistics Health, Inc., Wellpeek Merger Sub 1, Inc., Wellpeek Merger Sub 2, LLC, Peek Healthcare Technologies, Inc., and the Stockholder Representative (incorporated by reference to Exhibit 2.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 11, 2025).

Certificate of Incorporation of Wellgistics Health, Inc., as amended and currently in effect (incorporated by reference to Exhibit 3.1 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Bylaws of Wellgistics Health, Inc.

as currently in effect (incorporated by reference to Exhibit 3.2 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Form of Lock-Up Agreement (incorporated by reference to Exhibit 1.1 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Second Amended and Restated 2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.4 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025)

Executive Employment Agreement dated January 1, 2023, by and between Suren Ajjarapu and Wellgistics Health, Inc.

(incorporated by reference to Exhibit 10.6 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Executive Employment Agreement dated January 1, 2023, by and between Dr.

Shafaat Pirani and Wellgistics Health, Inc.

(incorporated by reference to Exhibit 10.7 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Executive Employment Agreement dated January 1, 2023, by and between Prashant Patel and Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) (incorporated by reference to Exhibit 10.8 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Executive Employment Agreement dated January 1, 2023, by and between Nikul Panchal and Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) (incorporated by reference to Exhibit 10.9 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Executive Employment Agreement dated March 3, 2025, by and between Wellgistics Health, Inc.

and Brian Norton (incorporated by reference to Exhibit 5.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on March 6, 2025).

Indemnification Agreement dated January 9, 2024, by and between Tim Canning and Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) (incorporated by reference to Exhibit 10.10 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025)

Contract Agreement dated April 15, 2024, by and between Aletheia Strategic Advisory LLC and Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) (incorporated by reference to Exhibit 10.11 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Lease Agreement dated March 23, 2024, by and between GVI-IP TAMPA OFFICE OWNER, LLC and Wellgistics, LLC and Wellgistics Health, Inc (f/k/a Danam Health, Inc.) (incorporated by reference to Exhibit 10.12 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025)

Promissory Note dated August 22, 2023, made by Wood Sage, LLC in favor of Integral Health, Inc.

(incorporated by reference to Exhibit 10.13 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Promissory Note dated January 12, 2024, made by Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) in favor of Strategic EP LLC (incorporated by reference to Exhibit 10.14 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Promissory Note effective September 14, 2023, made by TRxADE, Inc.

in favor of Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) Promissory Note effective September 14, 2023, made by TRxADE, Inc.

in favor of Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) (incorporated by reference to Exhibit 10.15 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Promissory Note dated September 13, 2023, made by Wellgistics Health, Inc.

(f/k/a Danam Health, Inc.) in favor of Nomad Capital LLC (incorporated by reference to Exhibit 10.16 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Loan and Security Agreement dated November 22, 2024, by and between Marco Capital, Inc.

and Wellgistics, LLC (incorporated by reference to Exhibit 10.17 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Guaranty Agreement dated as of November 22, 2024, by Wellgistics Health, Inc.

(formerly Danam Health, Inc.) in favor of Marco Capital, Inc.

(incorporated by reference to Exhibit 10.18 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Services Agreement dated July 12, 2023, by and between Roadie, Inc.

and Alliance Pharma Solutions, LLC dba DelivMeds (incorporated by reference to Exhibit 10.19 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Integration and Delivery Services Agreement dated January 26, 2022, by and between Lyft Healthcare, Inc.

and Alliance Pharma Solutions, LLC d/b/a DelivMeds (incorporated by reference to Exhibit 10.20 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Master Services Agreement dated November 20, 2023, by and between Best Computer Systems, Inc.

d/b/a BestRx Pharmacy Software and DelivMeds (incorporated by reference to Exhibit 10.21 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

340B Contract Pharmacy Services Agreement dated April 1, 2021, by and between Community Specialty Pharmacy, LLC and AIDS Service Association of Pinellas, Inc.

dba EPIC (incorporated by reference to Exhibit 10.22 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Participating Pharmacy Agreement dated February 6, 2023, by and between Medzoomer, Inc.

and Community Specialty Pharmacy Inc.

(incorporated by reference to Exhibit 10.23 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Standard Merchant Cash Advance Agreement dated October 1, 2024, by and between Cedar Advance LLC and Wellgistics LLC / Danam Health, Inc.

(incorporated by reference to Exhibit 10.24 of Wellgistics Health, Inc.’s amended Registration Statement on Form S-1/A filed with the SEC on January 14, 2025).

Consulting Agreement dated February 25, 2025, by and between Wellgistics Health, Inc.

and Hudson Global Ventures, LLC (incorporated by reference to Exhibit 1.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on February 28, 2025).

Consulting Agreement by and between Wellgistics Health, Inc.

and Draper, Inc.

dated March 17, 2025 (incorporated by reference to Exhibit 10.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on March 21, 2025).

Promissory Note made by Wellgistics Health, Inc.

dated April 4, 2025 (incorporated by reference to Exhibit 10.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 11, 2025).

Equity Purchase Agreement by and between Wellgistics Health, Inc.

and Hudson Global Ventures, LLC, dated April 9, 2025 (incorporated by reference to Exhibit 10.2 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 11, 2025).

Registration Rights Agreement by and between Wellgistics Health, Inc.

and Hudson Global Ventures, LLC, dated April 9, 2025 (incorporated by reference to Exhibit 10.3 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 11, 2025).

Form of Certificate of Amendment (incorporated by reference to Exhibit 3.1 of Form 8-K filed with the SEC on May 21, 2026).

Certificate of Amendment to Amended and Restated Certificate of Incorporation dated July 20, 2026 (incorporated by reference to Exhibit 3.1 to Form 8-K filed with the SEC on July 21, 2026).

Form of Convertible Promissory Note (incorporated by reference to Exhibit 4.1 of Form 8-K filed with the SEC on May 29, 2026).

Form of PIPE Warrant (incorporated by reference to Exhibit 4.2 of Form 8-K filed with the SEC on May 29, 2026).

Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.3 to Form 8-K/A filed with the SEC on June 3, 2026).

Amendment to Note Purchase Agreement, dated May 19, 2026 (incorporated by reference to Exhibit 10.2 of Form 8-K filed with the SEC on May 21, 2026).

Amended and Restated Promissory Note dated May 19, 2026 (incorporated by reference to Exhibit 10.3 of Form 8-K filed with the SEC on May 21, 2026).

Securities Purchase Agreement, dated May 27, 2026, by and among Wellgistics Health, Inc.

and the Purchasers party thereto (incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on May 29, 2026).

Registration Rights Agreement, dated May 27, 2026, by and among Wellgistics Health, Inc.

and the Purchasers party thereto (incorporated by reference to Exhibit 10.2 to Form 8-K filed with the SEC on May 29, 2026).

Placement Agency Agreement, dated May 27, 2026, by and between Wellgistics Health, Inc.

and Dawson James Securities, Inc.

(incorporated by reference to Exhibit 10.3 to Form 8-K filed with the SEC on May 29, 2026).

Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.4 to Form 8-K filed with the SEC on May 29, 2026).

Amended and Restated Letter of Intent dated July 29, 2026 (incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on August 4, 2026).

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

11 unchanged sentences

Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)

permitted by Regulation S-K, Item 601(b)(10)(iv) of the Securities Exchange Act of 1934, as amended, certain confidential portions

of this exhibit have been redacted from the publicly filed document.

The Company agrees to furnish supplementally an unredacted copy

of the exhibit to the Securities and Exchange Commission upon its request.

a management contract or any compensatory plan, contract or arrangement.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

August 17, 2026

Prashant Patel

2 unchanged sentences

Financial Officer and Accounting Officer)

August 17, 2026

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information